MENU
XLV
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

XLV stock forecast, quote, news & analysis

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index... Show more

Category: #Health
XLV
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for XLV with price predictions
Jul 13, 2026

Momentum Indicator for XLV turns positive, indicating new upward trend

XLV saw its Momentum Indicator move above the 0 level on June 25, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for XLV just turned positive on June 25, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for XLV moved above the 200-day moving average on July 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 261 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XLV moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where XLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XLV broke above its upper Bollinger Band on June 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Pfizer (NYSE:PFE).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the State Street®HlthCrSelSectSPDR®ETF ETF is 98.37B. The market cap for tickers in the group ranges from 9.25B to 1.05T. LLY holds the highest valuation in this group at 1.05T. The lowest valued company is UHS at 9.25B.

High and low price notable news

The average weekly price growth across all stocks in the State Street®HlthCrSelSectSPDR®ETF ETF was 6%. For the same ETF, the average monthly price growth was 35%, and the average quarterly price growth was 120%. CI experienced the highest price growth at 8%, while MRNA experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the State Street®HlthCrSelSectSPDR®ETF ETF was -25%. For the same stocks of the ETF, the average monthly volume growth was -17% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 45
Price Growth Rating: 36
SMR Rating: 58
Profit Risk Rating: 76
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
XLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Momentum Indicator for XLV turns positive, indicating new upward trend